RAJAF — Cordyceps Sunshine Biotech Holdings Co Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMid Cap
- $951.19m
- $951.60m
- $0.88m
Annual balance sheet for Cordyceps Sunshine Biotech Holdings Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 20-F | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0 | 0.1 | 0.007 | 0.015 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.244 | 0.511 | 0.009 | 0.12 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 0.949 | 1.12 | 0.502 | 0.331 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 1.73 | 1.99 | 0.254 | 3.05 |
| Other Long Term Assets | ||||
| Total Assets | 2.83 | 3.25 | 2.1 | 3.42 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 2.41 | 2.91 | 2.52 | 2.93 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 2.84 | 3.53 | 3.06 | 3.5 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -0.013 | -0.276 | -0.951 | -0.079 |
| Total Liabilities & Shareholders' Equity | 2.83 | 3.25 | 2.1 | 3.42 |
| Total Common Shares Outstanding |